Michael A. Martorelli01.22.09
Outsourcing M&A Year In Review
Reviewing 2008’s mergers, acquisitions and buyouts
By Michael A. Martorelli
This time, it was different. While the extent of consolidation in outsourcing in 2008 was not bad, we suspect it would have been stronger had it not been for deteriorating economic and capital market conditions. Moreover, the uneven financial results of some drug development firms and outsourcing service providers probably inhibited many contemplated transactions from coming to fruition. In the pages that follow, we comment on patterns of consolidation activity within various outsourcing segments, and on the details of specific transactions. First, we think it’s useful to examine the broader backdrop to all consolidation activity.
The Nature of Overall Consolidation Activity
Cons
Continue reading this story and get 24/7 access to Contract Pharma for FREE
FREE SUBSCRIPTION
